Company intelligence / Profile preview

Corgenix Medical Corporation

Broomfield, Colorado, United States

Ownership: Private
Employees: ~36
Development stage: Other

Overview

Corgenix develops, manufactures, and runs specialized in vitro diagnostic assays and laboratory services for cardiovascular risk, coagulation disorders, liver fibrosis, and emerging infectious diseases, and operates as a CAP/CLIA-accredited lab and contract development and manufacturing partner for IVD and clinical trial testing.[1][2][3][4]

Therapeutic areas: HematologyImmunologyCardiovascularInfectious DiseasesGastroenterology
Modalities: DeviceDiagnostic assayIn vitro diagnostic
Industry: Protein Biomarker Diagnostics

Partnerships

ELITech GroupTulane University and Viral Hemorrhagic Fever ConsortiumUS ArmyChugai Pharmaceutical

Beyond the preview

Go deeper on Corgenix Medical Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corgenix Medical Corporation.

Explore the full profile